This week, the P4A team discuss a new experimental therapy - Phage therapy or genetically engineered phages in order to treat bacterial infections and the acquisition of Theracon by Big Pharma firm Pfizer for upto $810 million.
Presenter: Aparna Krishnan
Contributor: Ciaran Cassidy
Producer: Aparna Krishnan
